# Amundi Index Solutions - Prime Europe (PRIE)

**Source:** https://fundology.uk/fund/prie · ISIN LU1931974262 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, PRIE (Amundi Index Solutions - Prime Europe, ISIN LU1931974262) closed at £31.30 on the London Stock Exchange. Its ongoing charge is 0.21% a year (about £21 on £10,000). Over the five years to 30/09/2026 its total return was +63.8%, or +28.0% after UK CPIH inflation.

## Summary

Amundi Index Solutions - Prime Europe is an exchange-traded fund (ETF) from Amundi, launched in 2019. It tracks the Solactive GBS Developed Markets Europe Large & Mid Cap EUR Index NTR. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.21% a year — about £21 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year.

Latest close: **£31.30** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | PRIE |
| ISIN | LU1931974262 |
| Category | European shares |
| Type | ETF |
| Provider | Amundi |
| Tracks | Solactive GBS Developed Markets Europe Large & Mid Cap EUR Index NTR |
| Income | Distributing |
| Ongoing charge | 0.21% a year (£21 per £10,000) |
| Fund size | £173m |
| Launched | 2019 |
| Domicile | Luxembourg |

## Past returns (periods to 30/09/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +16.60% | +12.94% | income reinvested |
| 3 years | +52.89% | +37.96% | income reinvested |
| 5 years | +63.77% | +28.02% | income reinvested |

Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Amundi Index Solutions - Prime Europe in pounds (price only, income paid out not included): 2022 −6.6%, 2023 +10.1%, 2024 +0.9%, 2025 +22.5%; 2026 to 30/09/2026 +8.8%. Returns of Amundi Index Solutions - Prime Europe in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +13.3%; to 30/09/2025: +9.6%; to 30/09/2024: +12.6%; to 30/09/2023: +14.4%; to 30/09/2022: −12.4%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | -6.6% | -14.5% | Price |
| 2023 | +10.1% | +5.7% | Price |
| 2024 | +0.9% | -2.5% | Price |
| 2025 | +22.5% | +18.3% | Price |
| 2026 to 30/09/2026 | +8.8% | +5.7% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 13.13% | -10.55% |
| 3 years | 12.28% | -10.55% |
| 5 years | 13.64% | -16.91% |

## Largest fall

Volatility of Amundi Index Solutions - Prime Europe in pounds, annualised from weekly returns to 30/09/2026: 13.1% over 1 year, 12.3% over 3 years, 13.6% over 5 years. Largest fall in the price of Amundi Index Solutions - Prime Europe since October 2021, in pounds: −16.9% from 12/11/2021 to 04/03/2022. The lowest 12-month return of Amundi Index Solutions - Prime Europe in pounds (price only, income paid out not included) since January 2021 was −12.5% (12 months to 14/10/2022); the highest was +27.0% (12 months to 10/04/2026). On 30/09/2026 the price of Amundi Index Solutions - Prime Europe was 3.3% below its highest weekly close since October 2021 (06/08/2026), in pounds.

## Charges compared with similar funds

Ongoing charge of Amundi Index Solutions - Prime Europe 0.21% a year, as of 01/10/2026: 117 of the 225 other European share funds charge more, 2 the same and 106 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.21%** per year
- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 29/09/2026):

| Holding | Weight |
|---|---|
| ASML | 5.10% |
| HSBC | 2.54% |
| Roche | 2.18% |
| Shell | 1.96% |
| Novartis Ag-Reg | 1.94% |
| AstraZeneca | 1.82% |
| Nestle Sa-Reg | 1.74% |
| Siemens Ag-Reg | 1.70% |
| SAP SE / Xetra | 1.59% |
| Banco Santander SA Madrid | 1.52% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By sector

As published by Amundi, as of 29/09/2026.

| Sector | Weight |
|---|---|
| Financials | 26.2% |
| Industrials | 18.3% |
| Health Care | 12.8% |
| Information Technology | 9.6% |
| Consumer Staples | 8.2% |
| Consumer Discretionary | 5.9% |
| Energy | 5.6% |
| Materials | 5.3% |
| Other sectors | 8.1% |

### By country

As published by Amundi, as of 29/09/2026.

| Country | Weight |
|---|---|
| United Kingdom | 22.8% |
| France | 13.6% |
| Germany | 13.5% |
| Switzerland | 13.3% |
| Netherlands | 9.1% |
| Sweden | 6.0% |
| Spain | 5.9% |
| Italy | 5.3% |
| Other countries | 10.4% |

All 395 holdings: https://fundology.uk/fund/prie/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.
